• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,136.76 949.89
( 1.23%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.26 0.11
(0.12%)
EUR-INR
110.12 0.41
(0.38%)
GBP-INR
129.49 0.88
(0.69%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
35.16
868.95
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.07
 

ncc ltd
Welspun Living consolidated net profit declines 21.33% in the March 2026 quarter
May 15,2026
Net profit of Welspun Living declined 21.33% to Rs 103.70 crore in the quarter ended March 2026 as against Rs 131.82 crore during the previous quarter ended March 2025. Sales declined 7.95% to Rs 2435.43 crore in the quarter ended March 2026 as against Rs 2645.90 crore during the previous quarter ended March 2025.

For the full year,net profit declined 68.01% to Rs 204.44 crore in the year ended March 2026 as against Rs 639.16 crore during the previous year ended March 2025. Sales declined 10.87% to Rs 9399.11 crore in the year ended March 2026 as against Rs 10545.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2435.432645.90 -8 9399.1110545.09 -11
OPM %10.2311.93 -8.4412.31 -
PBDT228.27260.93 -13 700.531233.57 -43
PBT125.20168.09 -26 306.44860.18 -64
NP103.70131.82 -21 204.44639.16 -68